Experimental Treatment Increases Skin Cancer Survival Rate by 25% - SciTechDaily

6/25/2022 12:00:00 AM2 years 10 months ago
Experimental treatment with a protein-derived molecule reduced tumor growth and metastasis as well as increased the survival rate by 25% A recent study published in Scientific Reports demonstrates the effectiveness of Rb4, a peptide developed by Brazilian sci…
ByFundação de Amparo à Pesquisa do Estado de São PauloJune 25, 2022 Cells treated with the experimental peptide Rb4 did not replicate and formed clusters, losing their natural morphology after just … [+7232 chars]
full article...